Neuropharmacological Treatment of Mental Dysfunction in Parkinson’s Disease

Many patients with Parkinson's Disease (PD) experience significant cognitive and mood impairment -even early in the course of the disease. These mental impairments are only partially responsive to levodopa treatment and are often as disabling as the motor impairment, particularly in mid and lat...

Descripción completa

Detalles Bibliográficos
Autores principales: McNamara, Patrick, Durso, Raymon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471533/
https://www.ncbi.nlm.nih.gov/pubmed/16720959
http://dx.doi.org/10.1155/2006/138263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471533/
https://www.ncbi.nlm.nih.gov/pubmed/16720959
http://dx.doi.org/10.1155/2006/138263

Ejemplares similares